Skip to main content
. Author manuscript; available in PMC: 2022 Apr 9.
Published in final edited form as: ACS Infect Dis. 2021 Mar 16;7(4):826–837. doi: 10.1021/acsinfecdis.0c00682

Table 2.

Avibactam Inhibitory Concentrations (IC50) Using Crude Protein Extracts from E. coli Producing the Different Variants and Wild-Type PenA1a

β-lactamase avibactam IC50 (μM)
PenA1 1
R220A 31
T237A 0.12
S130A >500
K234A >800
N170A 2.6
D276A 1
a

100 μM nitrocefin was used for all trials as the substrate.